• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    22.81 Down 0.14(0.61%) Dec 19, 4:00PM EST
    |After Hours : 22.81 0.00 (0.00%) Dec 19, 5:00PM EST
    Add to Portfolio
    Prev Close:22.95
    Open:22.92
    Bid:18.90 x 100
    Ask:24.99 x 1000
    1y Target Est:34.38
    Beta:-0.28
    Earnings Date:Feb 24 - Mar 2 (Est.)
    Day's Range:22.48 - 23.57
    52wk Range:19.10 - 74.58
    Volume:1,458,789
    Avg Vol (3m):1,245,390
    Market Cap:648.60M
    P/E (ttm):N/A
    EPS (ttm):-1.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 0.61%648.60M
    AZNDown 0.58%90.54B
    MRKUp 1.02%169.86B
    PFEDown 0.09%201.24B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.99
    Quarterly EPS Est (Dec-14) :-0.03
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):-1.45

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback